3 June 2025 (Geneva, Switzerland) – IAS – the International AIDS Society – announced today that AIDS 2026, the 26th International AIDS Conference, will take place in Rio de Janeiro, Brazil, and ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

FRIDAY, June 6, 2025 (HealthDay News) — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events.

You learn something new every day (though with the Republican crack-down on education and villainizing of scientists, who knows how much longer that will ...

Jefferies analyst Michael Yee reaffirmed a Buy rating on Gilead Sciences Inc. (NASDAQ:GILD), maintaining his price target at ...

Temalangeni Dlamini, 20, traveled 10 kilometers from her rural home in southern Eswatini to the Matsanjeni Health Centre for ...

Harrison, who was 21 at the time, showed neither signs nor symptoms related to the virus, and was in a long-term relationship. Young and carefree, Harrison had rarely given her health a second thought ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...